Colorectal cancer screening in Canada: It's time to act

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 2, 2003, Pages 178-179

  Schabas, Richard E ^a  

^a York Central Hospital Richmond Hill   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CARCINOMA; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FECES ANALYSIS; HUMAN; LABORATORY DIAGNOSIS; NOTE; OCCULT BLOOD; SIGMOIDOSCOPY;

EID: 0037248893     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (21)

1. National Committee on Colorectal Cancer Screening. Recommendations for population-based colorectal cancer screening. Ottawa: Health Canada; 2002. Available: www.hc-sc.gc.ca/pphb-dgspsp/publicat/ncccs-cndcc/index.html (accessed 2002 Dec 20).
2. Canadian Cancer Society. Population-based colorectal cancer screening: position statement. Toronto: The Society; 2003. Available: www.cancer.ca
3. National Cancer Institute of Canada. Canadian cancer statistics 2001. Toronto: The Institute; 2001. p. 61. Available: 66.59.133.166/stats/index.html (accessed 2002 Nov 14).
4. National Cancer Institute of Canada. Canadian cancer statistics 2002. Toronto: The Institute: 2002. p. 19. Available: www.cancer.ca/files/stats2002_e.pdf (accessed 2002 Nov 14).
5. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328(19):1365-71.
6. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
7. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
8. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343(22):1603-7.
9. McLeod RS and members of the Canadian Task Force on Preventive Health Care. Screening strategies for colorectal cancer: a systematic review of the evidence. Can J Gastroenterol 2001;15(10):647-60.
10. Ontario Expert Panel. Colorectal cancer screening: final report. Toronto: Cancer Care Ontario; 1999. Available: www.cancercare.on.ca/colorectal.pdf (accessed 2002 Nov 14).
11. Canadian Task Force on Preventive Health Care. Colorectal cancer screening. CMAJ 2001;165(2):206-8.
12. Agence d'évaluation des technologies et des modes d'intervention en santé. Colorectal cancer screening. Montreal: Conseil d'évaluation des technologies de la santé du Québec; 2000. Summary available: www.aetmis.gouv.qc.ca/fr/publications/scientifiques/depistage_genetique/ 1999_02_res_en.pdf (accessed 2002 Nov 27).
13. Canadian Coordinating Office for Health Technology Assessment. Economic evaluation of population-based screening for colorectal cancer. No. 6. Ottawa: The Office; 2002.
14. Wagner JL, Tunis S, Brown M, Ching A, Almeida R. Cost-effectiveness of colorectal cancer screening in average risk adults. In: Young GP, Prozen A, Levin B, editors. Prevention and early detection of colorectal cancer. London: WB Saunders; 1996.
15. Sonnenberg A, Delco F. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med 2002;162(2):163-8.
16. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing; results after 13 years and seven biennial screening rounds. Gut 2002;50(1):29-32.
17. Libstug AR, Moravan V, Aitken SE. Results from the Ontario breast screening program, 1990-1995. J Med Screen 1998;5:73-80.
18. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington: American Institute for Cancer Research; 1997.
19. Marrett LD, Theis B, Ashbury FD. Workshop report: physical activity and cancer prevention. Chronic Dis Can 2000;21(4):143-9.
20. Baron JA, Cole BF, Mott LA. Aspirin chemoprevention of colonic adenomas [abstract]. Proc Am Assoc Cancer Res 2002;43:669.
21. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, et al. Calcium supplements for the prevention of colorectal adenomas. Polyp Prevention Study Group. N Engl J Med 1999;340(2):101-7.